Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 5.10
+0.61 (13.59%)
Jun 30, 2026, 4:00 PM EST
Medexus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -2.39 | 2.25 | -0.21 | 1.22 | -2.88 |
Depreciation & Amortization | 9.73 | 7.18 | 5.81 | 6.08 | 6.14 |
Other Amortization | - | - | - | - | 0 |
Loss (Gain) From Sale of Assets | -0.41 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | 2.8 | 0.89 | - | 1.75 |
Stock-Based Compensation | 0.2 | 0.41 | 0.47 | 1.22 | 1.88 |
Other Operating Activities | 6.8 | 5.55 | 9.42 | 5.3 | -12.81 |
Change in Accounts Receivable | -1.45 | 10.54 | -1.68 | -8.24 | 4.43 |
Change in Inventory | 5.35 | -4.6 | -6.75 | -1.99 | -6.66 |
Change in Accounts Payable | - | - | 8.58 | 4.75 | 3.61 |
Change in Other Net Operating Assets | 1.05 | -0.1 | 2.19 | -9.79 | 3.36 |
Operating Cash Flow | 18.87 | 24.03 | 18.71 | -1.44 | -1.18 |
Operating Cash Flow Growth | -21.47% | 28.43% | - | - | - |
Capital Expenditures | -0.15 | -0.18 | -0.05 | -0.06 | -0.1 |
Sale of Property, Plant & Equipment | 0.65 | - | - | - | - |
Cash Acquisitions | -2.9 | -3.28 | -3.21 | -1.36 | -0.48 |
Sale (Purchase) of Intangibles | -15 | -2.54 | -0.22 | -0.3 | -7.62 |
Investing Cash Flow | -17.4 | -6 | -3.48 | -1.72 | -8.2 |
Long-Term Debt Issued | 25.57 | - | 17.58 | 35.46 | 3.89 |
Long-Term Debt Repaid | -41.38 | -14.24 | -43.99 | -24.72 | -0.16 |
Net Debt Issued (Repaid) | -15.81 | -14.24 | -26.4 | 10.73 | 3.73 |
Issuance of Common Stock | 0.5 | 19.3 | 7.61 | - | - |
Repurchase of Common Stock | -1.53 | - | - | - | - |
Other Financing Activities | -2.08 | -4.27 | -4.25 | -4.33 | -3.07 |
Financing Cash Flow | -18.92 | 0.8 | -23.05 | 6.41 | 0.66 |
Foreign Exchange Rate Adjustments | - | -0.11 | -0 | -0.19 | 0.03 |
Net Cash Flow | -17.45 | 18.72 | -7.81 | 3.05 | -8.69 |
Free Cash Flow | 18.72 | 23.85 | 18.66 | -1.51 | -1.28 |
Free Cash Flow Growth | -21.51% | 27.79% | - | - | - |
Free Cash Flow Margin | 18.85% | 22.02% | 16.51% | -1.39% | -1.67% |
Free Cash Flow Per Share | 0.58 | 0.90 | 0.84 | -0.07 | -0.06 |
Cash Interest Paid | 2.08 | 4.27 | 4.25 | 4.33 | 3.07 |
Cash Income Tax Paid | 0.98 | 0.22 | 1.42 | 0.91 | 0.68 |
Levered Free Cash Flow | -13.67 | 28.32 | 8.47 | -8.98 | -10.18 |
Unlevered Free Cash Flow | -10.42 | 33.44 | 16.83 | -0.48 | -2.54 |
Change in Working Capital | 4.94 | 5.84 | 2.34 | -15.26 | 4.73 |